Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis
ICD-10 N02.7 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with diffuse crescentic glomerulonephritis.
N02.7 refers to a condition characterized by recurrent and persistent hematuria, which is the presence of blood in the urine, associated with diffuse crescentic glomerulonephritis. This type of glomerulonephritis is marked by the formation of crescents in the glomeruli, indicating severe inflammation and damage to the kidney's filtering units. Patients typically present with symptoms such as hematuria, proteinuria, and varying degrees of renal impairment. The condition can be secondary to various underlying diseases, including autoimmune disorders, infections, or vasculitis. Diagnosis often involves renal biopsy, which reveals crescent formation and may show immunofluorescence patterns indicative of specific etiologies. Management typically includes immunosuppressive therapy, corticosteroids, and supportive care to control blood pressure and proteinuria. Early intervention is crucial to prevent progression to end-stage renal disease.
Detailed clinical notes on hematuria, renal function tests, and biopsy results.
Patients presenting with hematuria, proteinuria, and renal impairment requiring nephrology consultation.
Ensure that all laboratory results and imaging studies are documented to support the diagnosis.
Pathology reports detailing renal biopsy findings, including crescent formation and immunofluorescence results.
Biopsy specimens from patients with suspected glomerulonephritis.
Accurate reporting of histological findings is crucial for proper coding.
Used when a renal biopsy is performed to confirm crescentic glomerulonephritis.
Document indication for biopsy, findings, and any complications.
Nephrologists must ensure that the biopsy results are clearly linked to the diagnosis.
Crescentic glomerulonephritis indicates severe kidney damage and can lead to rapid renal failure if not treated promptly. It requires immediate medical attention and often aggressive treatment.
